Karyopharm Therapeutics Inc盘中异动股价大跌5.38%报0.724美元

自选股智能写手2023-11-16

北京时间2023年11月16日03时52分，Karyopharm Therapeutics Inc（KPTI.us）股票出现波动，股价急速下挫5.38%。截至发稿，该股报0.724美元/股，成交量39.5703万股，换手率0.35%，振幅9.14%。最近的财报数据显示，该股实现营业收入36.01百万美元，净利润-34.51百万美元，每股收益-0.30美元，毛利35.02百万美元，市盈率-0.56倍...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2383619869?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-11-16 03:52","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2383619869","market":"us","top_or_hot":-1,"title":"Karyopharm Therapeutics Inc盘中异动 股价大跌5.38%报0.724美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2023年11月16日03时52分，Karyopharm Therapeutics Inc（KPTI.us）股票出现波动，股价急速下挫5.38%。截至发稿，该股报0.724美元/股，成交量39.5703万股，换手率0.35%，振幅9.14%。最近的财报数据显示，该股实现营业收入36.01百万美元，净利润-34.51百万美元，每股收益-0.30美元，毛利35.02百万美元，市盈率-0.56倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231116035250839cec60&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Karyopharm Therapeutics Inc盘中异动 股价大跌5.38%报0.724美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKaryopharm Therapeutics Inc盘中异动 股价大跌5.38%报0.724美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-16 03:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231116035250839cec60&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2023年11月16日03时52分，Karyopharm Therapeutics Inc（KPTI.us）股票出现波动，股价急速下挫5.38%。截至发稿，该股报0.724美元/股，成交量39.5703万股，换手率0.35%，振幅9.14%。最近的财报数据显示，该股实现营业收入36.01百万美元，净利润-34.51百万美元，每股收益-0.30美元，毛利35.02百万美元，市盈率-0.56倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231116035250839cec60&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KPTI","symbol_name":"Karyopharm Therapeutics Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231116035250839cec60&s=b","article_id":"2383619869","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231116035250839cec60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2383619869","pubTimestamp":1700077969,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2023年11月16日03时52分，Karyopharm Therapeutics Inc股票出现波动，股价急速下挫5.38%。截至发稿，该股报0.724美元/股，成交量39.5703万股，换手率0.35%，振幅9.14%。Karyopharm Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.23%。Karyopharm Therapeutics Inc公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"KPTI":"Karyopharm Therapeutics Inc.","BK4139":"生物科技"},"translate_title":"Shares of Karyopharm Therapeutics Inc. tumbled 5.38 percent to $0.724 in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KPTI":0.9},"content_text":"北京时间2023年11月16日03时52分，Karyopharm Therapeutics Inc（KPTI.us）股票出现波动，股价急速下挫5.38%。截至发稿，该股报0.724美元/股，成交量39.5703万股，换手率0.35%，振幅9.14%。最近的财报数据显示，该股实现营业收入36.01百万美元，净利润-34.51百万美元，每股收益-0.30美元，毛利35.02百万美元，市盈率-0.56倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Karyopharm Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.23%。其相关个股中，Clene Inc C/Wts 30/12/2025 (To Pur Com)、Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)、Heron Therapeutics Inc涨幅较大，Scisparc Ltd、Chemomab Therapeutics Ltd、Kintara Therapeutics Inc较为活跃，换手率分别为2676.86%、663.44%、301.30%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028(To Pur Com)、Chemomab Therapeutics Ltd、Taysha Gene Therapies Inc，振幅分别为77.78%、67.21%、64.21%。Karyopharm Therapeutics Inc公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。XPOVIO (selinexor)在美国获批用于多种血液系统恶性肿瘤适应症，包括与Velcade(硼替佐米)和地塞米松联合用于至少接受过一种既往治疗后的多发性骨髓瘤成人患者的治疗，与地塞米松联合治疗患有严重预处理多发性骨髓瘤的成年患者，以及作为单一疗法用于复发或难治性弥漫性大B细胞淋巴瘤成人患者的治疗。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2383619869","isCrawlerRequest":true}

Karyopharm Therapeutics Inc盘中异动 股价大跌5.38%报0.724美元

精彩评论

Karyopharm Therapeutics Inc盘中异动股价大跌5.38%报0.724美元